Richard S. Levy
2014
In 2014, Richard S. Levy earned a total compensation of $2M as Executive Vice President and Chief Drug Development Officer at Incyte, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $292,180 |
|---|---|
| Option Awards | $974,998 |
| Salary | $402,977 |
| Stock Awards | $324,945 |
| Other | $6,818 |
| Total | $2,001,918 |
Levy received $975K in option awards, accounting for 49% of the total pay in 2014.
Levy also received $292.2K in non-equity incentive plan, $403K in salary, $324.9K in stock awards and $6.8K in other compensation.
Rankings
In 2014, Richard S. Levy's compensation ranked 4,513th out of 13,032 executives tracked by ExecPay. In other words, Levy earned more than 65.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,513 out of 13,032 | 65th |
Division Services | 751 out of 2,085 | 64th |
Major group Engineering, Accounting, Research, Management, And Related Services | 51 out of 190 | 73rd |
Industry group Research, Development, And Testing Services | 13 out of 58 | 78th |
Industry Commercial Physical and Biological Research | 13 out of 48 | 73rd |
Source: SEC filing on April 18, 2016.
Levy's colleagues
We found seven more compensation records of executives who worked with Richard S. Levy at Incyte in 2014.
2014
Hervé Hoppenot
Incyte
Chief Executive Officer
2014
David Gryska
Incyte
Chief Financial Officer
2014
Reid Huber
Incyte
Chief Scientific Officer
2014
James Daly
Incyte
Executive Vice President and Chief Commercial Officer
2014
David Hastings
Incyte
Chief Financial Officer
2014
Wenqing Yao
Incyte
Executive Vice President, Head of Discovery Chemistry
2014
Paul Friedman
Incyte